Miconazolnitraat/Hydrocortison Teva

Miconazole nitrate, the active ingredient in Miconazolnitraat/Hydrocortison Teva, is an antifungal presented as a topical formulation for skin use. Combined with hydrocortisone, a corticosteroid, the product treats fungal infections and inflammatory skin conditions such as ringworm, cutaneous candidiasis and eczema in adults and children.

GNH USA supplies Miconazolnitraat/Hydrocortison Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and adhering to stringent quality standards.

Miconazolnitraat/Hydrocortison Teva is used to treat fungal and inflammatory skin conditions. - Dermatophytosis (ringworm): Reduces fungal growth and alleviates associated inflammation and itching. - Cutaneous candidiasis: Eradicates Candida species on the skin while decreasing redness and discomfort. - Eczema/dermatitis: Provides anti‑inflammatory relief, reducing swelling, redness and pruritus in inflamed skin.

Topical application of Miconazolnitraat/Hydrocortison Teva may be associated with local adverse reactions.

Common Side Effects: - Burning sensation: Mild transient burning at the application site. - Itching: Slight pruritus may occur. - Redness: Local erythema can appear. - Dryness: Skin may become dry or flaky. - Stinging: Temporary stinging sensation. - Peeling: Minor skin peeling may be observed.

Serious or Rare Side Effects: - Contact dermatitis: Allergic skin reaction with swelling and rash. - Skin atrophy: Thinning of the skin with prolonged use. - Hypersensitivity: Systemic allergic response such as urticaria. - Secondary infection: Overgrowth of bacteria or non‑target fungi. - Hormonal effects: Rare systemic glucocorticoid effects with extensive application. - Delayed wound healing: Slower healing of cuts or abrasions.

Before using Miconazolnitraat/Hydrocortison Teva, consider the following precautions. - Avoid on broken skin: Do not apply to open wounds or severe abrasions. - Limit duration: Use only for the prescribed period to reduce risk of skin atrophy. - Monitor for allergy: Discontinue if signs of allergic reaction develop. - Use sparingly on face: Apply thin layer to facial areas to minimize irritation. - Pediatric use: Follow pediatric dosing guidance from a healthcare professional. - Store at room temperature: Keep below 25 °C, in the original container, protected from moisture and light.

Miconazolnitraat/Hydrocortison Teva can interact with certain topical and systemic agents.

Major Interactions (Avoid): - Occlusive dressings: Enhance systemic absorption of hydrocortisone, increasing side‑effect risk. - Potent CYP450 inhibitors: May increase miconazole levels when used concurrently on large skin areas.

Moderate Interactions (Monitor Closely): - Other topical steroids: Additive corticosteroid effects may raise risk of skin thinning. - Antifungal agents: Concurrent use may lead to excessive local antifungal activity. - Systemic corticosteroids: May augment overall glucocorticoid exposure. - Immunosuppressants: Monitor for increased susceptibility to infections.